5 investors are betting big on Diebold Nixdorf (DBD) stock
Source: Tada Images / Shutterstock.com
One of the biggest movers in today’s market is Diebold Nixdorf (NYSE:JDB). Unfortunately for investors, that’s because DBD stock plunged more than 55% during today’s session.
As a comrade InvestorPlace Contributor William White pointed out in a recent article that this decline is linked to the publication of the company’s annual letter to shareholders. In that letter, the company highlighted various liquidity issues that are prompting investors to sell today.
In addition, the company filed a proxy statement prior to its shareholders’ meeting. This statement indicates that the company may seek to increase its number of authorized shares in an effort to bolster its liquidity.
As a business closely tied to the banking industry, any talk of liquidity is not a good thing. Indeed, over the past week, we’ve seen some pretty notable banks collapse. As a result, expectations that small-cap companies could suffer a similar fate caused DBD shares to tumble during today’s session.
That said, let’s take a look at which institutional investors may have the most exposure to this company right now.
Top Five DBD Stock Investors
According Yahoo financeHere are Diebold Nixdorf’s top five institutional investors:
- Avant-garde owns 4.9 million shares or 6.3% of the company.
- black rock (NYSE:BLACK) owns 4.5 million shares or 5.7% of the company.
- Millennium Management, LLC owns 4 million shares or 5% of the company.
- Sapience Investments, LLC owns 3.9 million shares or 4.9% of the company.
- Beach Point Capital Management owns 2.9 million shares or 3.7% of the company.
On Penny Stocks and Low Volume Stocks:With rare exceptions, InvestorPlace does not publish reviews of companies with a market cap of less than $100 million or trading fewer than 100,000 shares per day. This is because these “penny stocks” are often the playground of scammers and market manipulators. If we ever post commentary on a low-volume stock that could be affected by our commentary, we require the editors of InvestorPlace.com to disclose that fact and warn readers of the risks.
Learn more:Penny Stocks – How To Profit Without Getting Scammed
As of the date of publication, Chris MacDonald had (neither directly nor indirectly) any position in the securities mentioned in this article. The opinions expressed in this article are those of the author, subject to InvestorPlace.com publishing guidelines.
InvestorPlace
